{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:38:53Z","timestamp":1792607933371,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Medical University of \u0141\u00f3d\u017a","award":["502-03\/5-165-01\/502-54-168"],"award-info":[{"award-number":["502-03\/5-165-01\/502-54-168"]}]},{"name":"Medical University of \u0141\u00f3d\u017a","award":["502-03\/5-165-01\/502-54-114"],"award-info":[{"award-number":["502-03\/5-165-01\/502-54-114"]}]},{"name":"University of \u0141\u00f3d\u017a","award":["506\/982"],"award-info":[{"award-number":["506\/982"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pharep.2015.08.019","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T23:20:54Z","timestamp":1443568854000},"page":"344-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Intensive statin therapy, used alone or in combination with ezetimibe, improves homocysteine level and lipid peroxidation to a similar degree in patients with coronary artery diseases"],"prefix":"10.1007","volume":"68","author":[{"given":"Edyta","family":"Pytel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Jackowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Chwatko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Olszewska-Banaszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Koter-Michalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Kubalczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Broncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2015.08.019_bib0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3132\/dvdr.2007.033","article-title":"Homocysteine and cardiovascular disease: a review of the evidence","volume":"4","author":"Wierzbicki","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.pharep.2015.08.019_bib0125","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.ATV.20.5.1182","article-title":"Hyperhomocysteinemia and oxidative stress: time for a reality check","volume":"20","author":"Jacobsen","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.pharep.2015.08.019_bib0130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1258\/acb.2007.007125","article-title":"Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes","volume":"45","author":"Kassab","year":"2008","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"10.1016\/j.pharep.2015.08.019_bib0135","first-page":"114","article-title":"The usefulness of assessing the serum levels of homocysteine in diagnosis of atherosclerosis","volume":"11","author":"Kokoci\u0144ska","year":"2005","journal-title":"Acta Angiol"},{"key":"10.1016\/j.pharep.2015.08.019_bib0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.1971.tb00790.x","article-title":"The autooxidation of red cell lipids by hydrogen peroxide","volume":"20","author":"Stocks","year":"1971","journal-title":"Br J Hematol"},{"key":"10.1016\/j.pharep.2015.08.019_bib0145","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1081\/JLC-100103450","article-title":"2-Chloro-1-methylquinolinium tetrafluoroborate as an effective and thiol specific UV-tagging reagent for liquid chromatography","volume":"24","author":"Bald","year":"2001","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"10.1016\/j.pharep.2015.08.019_bib0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.chroma.2003.11.030","article-title":"Analysis of plasma thiols by high-performance liquid chromatography with ultraviolet detection","volume":"1032","author":"Bald","year":"2004","journal-title":"J Chromatogr A"},{"issue":"1","key":"10.1016\/j.pharep.2015.08.019_bib0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3329\/jdmc.v21i1.13234","article-title":"Serum homocysteine levels in patients with acute myocardial infarction","volume":"21","author":"Alam","year":"2012","journal-title":"J Dhaka Med Coll"},{"key":"10.1016\/j.pharep.2015.08.019_bib0160","article-title":"Correlation of serum homocysteine levels with the severity of coronary artery disease","author":"Shenoy","year":"2013","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.pharep.2015.08.019_bib0165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"Nygard","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.pharep.2015.08.019_bib0170","first-page":"283","article-title":"Oxidative and nitrosative stress in association with DNA damage in coronary heart disease","volume":"52","author":"Rajesh","year":"2011","journal-title":"Singap Med J"},{"issue":"4","key":"10.1016\/j.pharep.2015.08.019_bib0175","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0025-6196(11)60544-2","article-title":"Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease","volume":"84","author":"Karalis","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.pharep.2015.08.019_bib0180","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/2047487313489875","article-title":"Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER database","volume":"26","author":"Palmer","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.pharep.2015.08.019_bib0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2013.02.027","article-title":"Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70mg\/dL or \u226550% reduction in high-risk patients: results from VOYAGER","volume":"228","author":"Karlson","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2015.08.019_bib0190","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2147\/VHRM.S49840","article-title":"Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy","volume":"9","author":"Foody","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.pharep.2015.08.019_bib0195","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0021-9150(00)00474-3","article-title":"Homocysteine and lipid lowering agents: a comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia","volume":"154","author":"Giral","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2015.08.019_bib0200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0008-6363(01)00382-0","article-title":"Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial-FAT)","volume":"52","author":"Malik","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharep.2015.08.019_bib0205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0021-9150(02)00318-0","article-title":"Letter to editor. Statins and homocysteine","volume":"166","author":"Miltiadous","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2015.08.019_bib0210","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0002-9149(01)02257-3","article-title":"Effects of Atorvastatin on oxidized low density lipoprotein, low density lipoprotein subfractions distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia","volume":"89","author":"Sasaki","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharep.2015.08.019_bib0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9150(00)00735-8","article-title":"High-dose simvastatin (80mg\/day) decreases plasma concentrations of total homocysteine in patients with hypercholesterolemia","volume":"155","author":"Luftjohann","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharep.2015.08.019_bib0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/1479164111430715","article-title":"Cardiovascular disease simvastatin\/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and comparative efficacy and safety of fenofibrate\/pravastatin plus ezetimibe triple therapy and cardiovascular disease","volume":"9","author":"Farnier","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.pharep.2015.08.019_bib0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacl.2011.08.006","article-title":"The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin","volume":"6","author":"Murrow","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.pharep.2015.08.019_bib0230","first-page":"216","article-title":"Effect of rosuvastatin on obesity-induced cardic oxidative stress in wistar rats \u2013 a preliminary study","volume":"50","author":"Ansari","year":"2012","journal-title":"Indian J Exp Biol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:15Z","timestamp":1752611775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.08.019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1734114015003217"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.08.019","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive statin therapy, used alone or in combination with ezetimibe, improves homocysteine level and lipid peroxidation to a similar degree in patients with coronary artery diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Sp. z o.o.","name":"copyright","label":"Copyright"}]}}